Italia markets closed

Teva Pharmaceutical Industries Limited (TEVJF)

Other OTC - Other OTC Prezzo differito. Valuta in USD.
Aggiungi a portafoglio
9,390,00 (0,00%)
Al 2:09PM EST. Mercato aperto.
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente9,39
Aperto9,39
DenaroN/D x N/D
LetteraN/D x N/D
Min-Max giorno9,39 - 9,39
Intervallo di 52 settimane8,50 - 13,65
Volume10
Media Volume255
Capitalizzazione10,355B
Beta (5 anni mensile)1,28
Rapporto PE (ttm)14,22
EPS (ttm)0,66
Prossima data utiliN/D
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendo28 nov 2017
Stima target 1AN/D
  • GlobeNewswire

    Quantum Genomics signs an exclusive license agreement with Teva Israel Ltd.

    Quantum Genomics will receive up to $11 M in payments and 25% minimum up to 30% royalties on future salesTeva will receive an exclusive license to bring firibastat to its home market, Israel PARIS, Nov. 25, 2021 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in the development of a new drug class directly targeting the brain to treat difficult-to-treat/resistant hypertension, has today announced the signing of an exclusive